SitemapKlarity storyJoin usMedicationServiceAbout us
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
4.9 based on 1,805 reviews
fsaAccept major insurances and cash-pay
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
4.9 based on 1,805 reviews
fsaAccept major insurances and cash-pay
Back

Published: Jun 9, 2026

Share

Psychiatric NP Scope of Practice for General Psychiatry in New York

Share

Written by Klarity Editorial Team

Published: Jun 9, 2026

Psychiatric NP Scope of Practice for General Psychiatry in New York
Table of contents
Share

If you’re a psychiatrist or PMHNP considering telehealth—or already running a telepsychiatry practice—you’ve probably asked yourself: Can I legally prescribe Adderall for ADHD over video? What about benzos for anxiety? Do I need an in-person visit first?

The answer depends on where your patient is located, what you’re prescribing, and whether you’re an MD or NP. Federal DEA rules set the baseline, but state laws often add extra steps—or carve out exceptions for mental health providers.

Here’s what you actually need to know in 2026 to prescribe controlled substances via telehealth without risking your license.


The Federal Picture: DEA Flexibilities Extended Through 2026

Good news first: As of February 2026, you can still prescribe Schedule II-V controlled substances via telehealth to new patients without an in-person exam—at least through December 31, 2026.

The DEA and HHS extended COVID-era telehealth prescribing flexibilities for the fourth time, preventing care disruptions while permanent rules are finalized. This means:

  • For existing patients you’ve seen in person at any point (even years ago), there’s no federal restriction on prescribing controlled substances via telehealth. You can manage ongoing ADHD, anxiety, or insomnia treatment entirely remotely.

  • For new patients you’ve never met in person, you can conduct a video evaluation and prescribe Schedule II-V medications (stimulants, benzos, buprenorphine) under the temporary extension—if it’s medically appropriate and meets the standard of care.

This suspension of the Ryan Haight Act’s in-person requirement has been a lifeline for telepsychiatry. But it’s temporary.


Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What’s Coming: DEA’s Proposed Permanent Rules

The DEA proposed three new rules in January 2025 that will reshape telehealth prescribing once finalized (likely late 2026):

1. Buprenorphine for Opioid Use Disorder

Psychiatrists treating OUD can prescribe buprenorphine via telehealth (including audio-only) for up to 6 months before requiring an in-person visit. This codifies what many addiction psychiatrists have been doing and removes the X-waiver entirely (already eliminated in 2023).

2. Special Telemedicine Registration for Schedule II

This is huge for general psychiatry. The DEA will allow board-certified psychiatrists (among a few other specialties) to obtain a Special Telemedicine Prescriber Registration to prescribe Schedule II controlled substances—like Adderall or Vyvanse for ADHD—to new patients via telehealth without any in-person exam.

For Schedule III-V meds (most benzos, some sleep meds), any qualified prescriber can get this registration.

The catch: Online telehealth platforms (like Klarity Health) will need to register with the DEA for the first time, and a national PDMP will track controlled prescriptions across state lines. This adds accountability but also legitimizes telepsychiatry by providing a clear legal pathway.

3. VA Continuity of Care

If a veteran had an in-person exam with any VA clinician, any VA telehealth provider (even in a different state) can prescribe controlled substances remotely. This won’t directly affect private practice, but it signals federal acceptance of telehealth continuity of care.

Timeline: These rules are open for public comment. Once finalized, expect stricter documentation requirements, but also more clarity and legitimacy for telehealth prescribers.


State-by-State Reality: Where the Rules Actually Differ

Federal law sets the floor, but state laws can be stricter—and they often are. Here’s what you need to know in six key states:

California

  • No state-level restrictions on telehealth prescribing of controlled substances beyond federal law
  • 📋 PDMP mandate: Check CURES database before prescribing Schedule II-IV, then every 4 months
  • 💊 100% e-prescribing required since 2022
  • 🩺 NP independence: PMHNPs with 3+ years experience can practice independently starting 2024-2026 (phased rollout)
  • Bottom line: CA is telehealth-friendly. Video exam establishes patient relationship; no in-person requirement.

Texas

  • ⚠️ NPs cannot prescribe Schedule II outside hospital/hospice settings—so ADHD meds for outpatient telepsychiatry must be prescribed by an MD/DO
  • 📋 PDMP check required for opioids, benzos, barbiturates
  • 🚫 Chronic pain prescribing via telehealth is prohibited without an in-person visit
  • 🩺 NPs need physician supervision for all practice
  • Bottom line: Texas allows psychiatric telehealth for MDs, but NPs face major scope limits. Platforms need physician backup for stimulants.

Florida

  • 🎯 Psychiatric carve-out: Schedule II controlled substances can be prescribed via telehealth if for psychiatric treatment (ADHD, mood disorders, etc.)—but not for pain management or other uses
  • 📋 PDMP check mandatory before any controlled Rx for patients ≥16
  • 🌍 Out-of-state registration available: Non-FL providers can register to treat Florida patients via telehealth (but still follow FL rules)
  • 🩺 NPs require physician collaboration (no independent practice for psych NPs)
  • Bottom line: Florida allows telepsychiatry for controlled substances if you’re treating mental health. Document the indication clearly.

New York

  • No state restrictions on telehealth controlled substance prescribing beyond federal law
  • 📋 Strict PDMP mandate: Must check PMP before prescribing every Schedule II-IV controlled substance
  • 💊 E-prescribing required for all prescriptions (not just controlled)
  • 🩺 NP independence: PMHNPs with 3,600+ hours can practice independently (no physician collaboration needed)
  • Bottom line: NY is highly telehealth-friendly for psychiatry. Experienced NPs have full autonomy.

Pennsylvania

  • 📋 PDMP check required for opioids and benzos
  • 🩺 NPs need collaborative agreements with at least two physicians for prescriptive authority
  • No comprehensive telehealth statute yet—practice governed by standard of care and board guidance
  • Bottom line: PA defers to federal law on telehealth prescribing. NPs need physician partners; MDs have full authority.

Illinois

  • 🩺 NPs can get Full Practice Authority after 4,000 hours + extra training—but must consult a physician for certain Schedule II prescribing (30-day limit)
  • 📋 PDMP check mandatory for opioids
  • 💊 E-prescribing required for all controlled substances as of 2023
  • Bottom line: IL is moving toward NP independence but still imposes some limits on Schedule II. MDs have no restrictions.

The Business Reality: Why Most Psychiatrists Don’t Go DIY

Here’s what most provider recruitment content won’t tell you: acquiring qualified psychiatric patients is expensive and time-consuming if you do it yourself.

The Real Cost of DIY Marketing

Let’s break down what it actually costs to acquire a patient through traditional channels:

SEO:

  • Takes 6-12 months of consistent investment before generating meaningful patient flow
  • Requires ongoing content creation, technical optimization, and link building
  • Most solo providers lack the expertise or patience for this

Google Ads:

  • Mental health keywords cost $15-40+ per click
  • Most clicks don’t convert to booked patients
  • Realistic cost per booked patient through PPC: $200-400+ when you factor in ad spend, wasted clicks, and optimization time

Directory Listings:

  • Psychology Today, Zocdoc, etc. charge monthly fees ($30-200+)
  • Zocdoc charges per booking ($35-100+ per lead)
  • You compete with hundreds of other providers on the same page
  • No guarantee of patient quality or specialty match

Total monthly marketing spend for a solo psychiatrist trying to fill a schedule: Easily $3,000-5,000/month with uncertain results—and that’s before counting staff time to handle and qualify leads, no-show rates from cold leads, and months of testing before finding what works.

The Klarity Model: Pay Only When Patients Book

Klarity Health uses a pay-per-appointment model (similar to Zocdoc) where you pay a standard listing fee per new patient lead. But here’s the difference:

  • No upfront marketing spend or monthly subscription fees
  • Pre-qualified patients already matched to your specialty and availability
  • No wasted ad spend on clicks that don’t convert
  • Built-in telehealth infrastructure (no separate platform costs)
  • Both insurance and cash-pay patient flow
  • You control your schedule—only pay when you see patients

The economic case: Instead of gambling $3,000-5,000/month on marketing with uncertain ROI, you pay only when a qualified patient books with you. That’s guaranteed ROI vs. marketing risk.

DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience—but for most providers (especially those starting out or scaling), a platform that handles patient acquisition removes the risk entirely.


Compliance Checklist: What You Must Do Now

Regardless of state, here’s what every telepsychiatry prescriber should be doing in 2026:

✅ Federal Requirements

  • [ ] Maintain valid DEA registration in each state where patients are located
  • [ ] Complete 8-hour MATE Act training on substance use disorder and pain management (required for DEA renewal since 2023)
  • [ ] Use two-way audio-video for initial controlled substance evaluations (audio-only only acceptable for buprenorphine follow-ups or established patients)
  • [ ] Document thorough psychiatric evaluation to establish patient-provider relationship
  • [ ] E-prescribe all controlled substances (DEA requires two-factor authentication)
  • [ ] Follow standard of care for controlled substance prescribing (appropriate diagnosis, treatment plan, monitoring)

✅ State Requirements

  • [ ] Hold active medical/nursing license in the state where the patient is physically located during the visit
  • [ ] Check state PDMP before prescribing controlled substances (required in CA, TX, FL, NY, PA, IL before initial Rx—check frequency varies by state)
  • [ ] If you’re an NP, ensure you have required physician collaboration in states that mandate it (TX, FL, PA)
  • [ ] If prescribing Schedule II via telehealth in Florida, document that it’s for psychiatric treatment (ADHD, mood disorder, etc.)
  • [ ] If practicing in Texas as an NP, do NOT prescribe Schedule II for outpatients—refer to MD colleague

✅ Platform/Practice Requirements

  • [ ] Use HIPAA-compliant telehealth platform
  • [ ] Obtain informed consent for telehealth services
  • [ ] Maintain malpractice insurance that covers telehealth and all states where you practice
  • [ ] Keep detailed clinical documentation (mental status exam, diagnosis, treatment plan, rationale for controlled substance if prescribed)

FAQ: What Providers Actually Ask

Can I prescribe Adderall to a new ADHD patient I’ve only seen via video?

Through December 31, 2026: Yes, under the DEA’s temporary extension—if you’re licensed in the patient’s state and it’s clinically appropriate.

After DEA’s final rules: Likely yes, if you’re a psychiatrist and obtain the proposed Special Telemedicine Registration. Check state law too (e.g., Texas NPs still can’t).

Do I need to see a patient in person eventually?

Not under current federal law through 2026. Once permanent rules take effect, psychiatrists may be able to continue telehealth-only care with the special registration. Buprenorphine patients would need an in-person visit after 6 months.

Best practice: For high-risk patients (substance use history, complex polypharmacy), consider requiring or strongly recommending at least one in-person visit for safety.

What if my patient moves to another state mid-treatment?

You need a license in the new state to continue treating them. Interstate compacts (IMLC for MDs, some states for NPs) can help speed this up. Otherwise, you’ll need to refer them to a local provider or pause care while you obtain licensure.

Can I use audio-only (phone) for psychiatric medication management?

For established patients: Generally acceptable if clinically appropriate (e.g., routine follow-up for stable patients).

For new patients or controlled substances: Not advisable except for buprenorphine (DEA explicitly allows audio-only for OUD treatment). Use video for initial evaluations and any time you’re prescribing Schedule II-IV meds.

What happens if I prescribe outside the rules?

State medical boards can discipline you (license suspension, fines). DEA can revoke your controlled substance registration. Insurance plans may deny claims or audit you. Worst case: criminal charges for illegal prescribing.

The stakes are real. When in doubt, consult your state board or a healthcare attorney.


The Path Forward: What to Do Next

If you’re serious about building or scaling a telepsychiatry practice in 2026:

  1. Get licensed in your target states (consider IMLC if you’re an MD and want to practice in multiple states)

  2. Understand your scope limits (especially if you’re an NP—state laws vary wildly)

  3. Implement compliance systems (PDMP checks, e-prescribing, documentation templates)

  4. Calculate your real patient acquisition costs (most providers are shocked when they add up all the hidden costs of DIY marketing)

  5. Consider platform economics (paying per qualified patient vs. gambling on marketing spend)

For many psychiatrists and PMHNPs, joining a platform like Klarity Health solves the patient acquisition problem while you focus on what you do best—treating patients. You get:

  • Pre-qualified patient flow (both insurance and cash-pay)
  • Built-in compliance infrastructure (HIPAA-compliant platform, e-prescribing integration)
  • No upfront marketing spend (pay only when patients book)
  • Control over your schedule (set your own availability)
  • Support navigating state licensing and credentialing

The alternative: Spend months building SEO, burning cash on Google Ads, and competing with hundreds of providers on directory sites—all while managing a solo practice and keeping up with changing regulations.

Most providers who’ve tried both will tell you: the DIY path looks cheaper on paper until you factor in the opportunity cost of all those hours spent on marketing instead of seeing patients.


Final Thought: Regulation is Clarifying, Not Restricting

Yes, DEA rules are getting more structured. Yes, state laws vary. But that’s actually good news for legitimate telepsychiatry providers.

The wild west phase of telehealth (where some platforms overprescribed stimulants with minimal oversight) is ending. What’s replacing it is a system where psychiatrists and PMHNPs who follow the rules have clear, legal pathways to deliver remote care.

If you’re doing thorough evaluations, documenting appropriately, and staying within your scope of practice, you have nothing to worry about. In fact, you’re better positioned than ever—because demand for psychiatric care is at an all-time high, and patients have fully embraced telehealth.

The question isn’t whether you can practice telepsychiatry legally. The question is whether you want to spend your time marketing or treating patients.


Ready to Join a Telehealth Platform That Handles Patient Acquisition for You?

Klarity Health connects psychiatrists and PMHNPs with pre-qualified patients seeking mental health care—no upfront costs, no marketing spend, no gambling on SEO or Google Ads.

You set your schedule. We handle everything else.

Explore joining Klarity’s provider network → [Learn more about becoming a Klarity provider]


Sources & References

  1. HHS Press Release: ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026’ (January 2, 2026) – www.hhs.gov

  2. DEA Press Release: ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Care’ (January 16, 2025) – www.dea.gov

  3. Florida Statutes §456.47: Use of Telehealth to Provide Services (2025 edition) – www.leg.state.fl.us

  4. Akerman LLP: ‘Harmonizing Federal and Florida Laws on Prescribing Controlled Substances Through Telehealth’ (March 2023) – www.akerman.com

  5. Texas Medical Board: Prescriptive Authority FAQs (Updated 2024) – www.tmb.texas.gov

Disclaimer: This content is for informational purposes only and does not constitute legal or medical advice. State and federal regulations change frequently. Always consult your state medical/nursing board and legal counsel for guidance on your specific situation.

Source:

Get expert care from top-rated providers

Find the right provider for your needs — select your state to find expert care near you.

Related posts

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402

Join our mailing list for exclusive healthcare updates and tips.

Stay connected to receive the latest about special offers and health tips. By subscribing, you agree to our Terms & Conditions and Privacy Policy.
logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402
If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Lifeline: call or text 988. Crisis Text Line: Text HOME to 741741.
HIPAA
© 2026 Klarity Health, Inc. All rights reserved.